Oncopharmpod
Pembrolizumab Nets 2 More Approvals
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:15:02
- Mas informaciones
Informações:
Sinopsis
Discussing recent FDA-approvals of pembrolizumab for metastatic or unresectable, recurrent Head & Neck Cancer (1st line) and Small Cell Lung Cancer (3rd line)
